CACPD2011a-0001278239
CACPD2011a-0001278239 is a β2AR mixed agonist that shows a wide range of high-affinity binding to both wild-type and T164I β2AR variants, with no cytotoxicity or mutagenicity, making it suitable for asthma research[1].
Product Specifications
CAS Number
1030781-08-8
UNSPSC
12352005
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cacpd2011a-0001278239.html
Smiles
OC1=CC=C(C=C1)C2=CCN(CC2)CC(NC3=CC(C(N)=O)=CC(C(N)=O)=C3)=O
Molecular Formula
C21H22N4O4
Molecular Weight
394.42
References & Citations
[1]Srinivas Bandaru, et al. In vitro evaluation of promiscuity and toxicity of a small molecule targeting wild and T164I β2-adrenergic receptors. Bioorg Chem. 2024 Dec:153:107990.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
β adrenergic receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402993-100 1x 100 µL
Renal Cell Carcinoma (Carbonic Anhydrase IX) (CA9/2993R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-B687755-50MG 50 mg
6-Bromo-6-deoxy-D-glucopyranose (a/b mixture)
Sign In for Pricing
View Details 
